Hudson Bay Capital Management LP Cassava Sciences Inc Transaction History
Hudson Bay Capital Management LP
- $24.1 Billion
- Q4 2024
A detailed history of Hudson Bay Capital Management LP transactions in Cassava Sciences Inc stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 30,000 shares of SAVA stock, worth $43,800. This represents 0.02% of its overall portfolio holdings.
Number of Shares
30,000Holding current value
$43,800% of portfolio
0.02%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding SAVA
# of Institutions
188Shares Held
16.4MCall Options Held
3.49MPut Options Held
8.08M-
Black Rock Inc. New York, NY3.22MShares$4.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.51MShares$3.67 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.01MShares$1.47 Million0.0% of portfolio
-
State Street Corp Boston, MA997KShares$1.46 Million0.0% of portfolio
-
Ubs Group Ag931KShares$1.36 Million0.0% of portfolio
About CASSAVA SCIENCES INC
- Ticker SAVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,097,900
- Market Cap $58.5M
- Description
- Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...